Cytokine Inhibition in Chronic Fatigue Syndrome Patients
Phase of Trial: Phase II/III
Latest Information Update: 07 Mar 2017
Price : $35 *
At a glance
- Drugs Anakinra (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Acronyms CiCFS
- 31 Aug 2018 Biomarkers information updated
- 07 Mar 2017 Primary endpoint (Fatigue severity-measured by the Checklist Individual Strength subscale (CIS-fatigue) at 4 weeks) has not been met, according to results published in the Annals of Internal Medicine Journal.
- 07 Mar 2017 Results published in the Annals of Internal Medicine Journal.